BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 9689204)

  • 1. Compliance considerations with hormone replacement therapy.
    Karakoç B; Erenus M
    Menopause; 1998; 5(2):102-6. PubMed ID: 9689204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of physicians' advice and recommendations on the compliance with hormone replacement therapy in the treatment of postmenopausal symptoms in Japanese women--a prospective study.
    Ushiroyama T; Ikeda A; Sakuma K; Ueki M
    J Med; 2004; 35(1-6):163-9. PubMed ID: 18084874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moderate dosage estrogen-androgen therapy improves continuation rates in postmenopausal women: impact of the WHI reports.
    Gambrell RD; Natrajan PK
    Climacteric; 2006 Jun; 9(3):224-33. PubMed ID: 16766436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone replacement therapy among Danish women aged 45-65 years: prevalence, determinants, and compliance.
    Oddens BJ; Boulet MJ
    Obstet Gynecol; 1997 Aug; 90(2):269-77. PubMed ID: 9241307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Attitudes toward estrogen replacement therapy. Study conducted on a sample population of women attending an ambulatory care center for the treatment of menopause].
    Perrone G; Capri O; Borrello M; Galoppi P
    Minerva Ginecol; 1993 Dec; 45(12):603-8. PubMed ID: 8139786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Important factors for use of hormone replacement therapy: a population-based study of Swedish women. The Women's Health in Lund Area (WHILA) Study.
    Li C; Samsioe G; Lidfelt J; Nerbrand C; Agardh CD;
    Menopause; 2000; 7(4):273-81. PubMed ID: 10914621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone replacement therapy in the post-Women's Health Initiative era. Report a a meeting held in Funchal, Madeira, February 24-25, 2003.
    Burger H
    Climacteric; 2003 May; 6 Suppl 1():11-36. PubMed ID: 12945798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy in postmenopausal women.
    Yasui T; Uemura H; Takikawa M; Irahara M
    J Med Invest; 2003 Aug; 50(3-4):136-45. PubMed ID: 13678382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compliance to hormone replacement therapy.
    Rozenberg S; Vandromme J; Kroll M; Pastijn A; Liebens F
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 1():23-32. PubMed ID: 7581586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Compliance with hormone replacement therapy].
    Rozenberg S; Vandromme J; Kroll M; Twagirayezu P; Vyankandondera J
    Rev Med Brux; 1995; 16(4):295-8. PubMed ID: 7481246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dilemma of menopause and hormone replacement--a challenge for women and health-care providers: knowledge of menopause and hormone therapy in Spanish menopausal women.
    Castelo-Branco C; Peralta S; Ferrer J; Palacios S; Cornago S; Quereda F
    Climacteric; 2006 Oct; 9(5):380-7. PubMed ID: 17000585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thoughts on individualizing hormone replacement therapy based on the postmenopausal health disparities study data.
    Gavaler JS
    J Womens Health (Larchmt); 2003 Oct; 12(8):757-68. PubMed ID: 14588126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. After the Women's Health Initiative: Postmenopausal women's experiences with discontinuing estrogen replacement therapy.
    Haskell SG
    J Womens Health (Larchmt); 2004 May; 13(4):438-42. PubMed ID: 15186661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spanish post-menopausal women's viewpoints on hormone therapy.
    Castelo-Branco C; Ferrer J; Palacios S; Cornago S; Peralta S
    Maturitas; 2007 Apr; 56(4):420-8. PubMed ID: 17174045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuation of hormone replacement therapy in Slovenia: a prospective, randomized, controlled trial--1-year follow-up.
    Franić D; Verdenik I; Meden-Vrtovec H; Svab I
    Maturitas; 2006 May; 54(2):110-8. PubMed ID: 16293377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of menopausal hormone therapy use pattern since 2000: results of the Berlin Spandau Longitudinal Health Study.
    Du Y; Scheidt-Nave C; Schaffrath Rosario A; Ellert U; Dören M; Knopf H
    Climacteric; 2009 Aug; 12(4):329-40. PubMed ID: 19437194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician counseling on hormone replacement therapy and bone loss: do socioeconomic and racial characteristics of women influence counseling?
    Neuner JM; McCarthy EP; Davis RB; Phillips RS
    J Womens Health (Larchmt); 2003 Jun; 12(5):495-504. PubMed ID: 12869297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone therapy use and prescription durations of menopausal women in Taiwan: a 5 years' National Cohort study.
    Kuo DJ; Lee YC; Huang WF
    Maturitas; 2007 Nov; 58(3):259-68. PubMed ID: 17920215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of hormone replacement therapy by menopausal women in six family-practice teaching clinics in Israel.
    Vinker S; Kaplan B; Yaphe J; Cohen O; Shumla V; Shapira G; Shofty I; Kitai E
    Climacteric; 2003 Mar; 6(1):75-80. PubMed ID: 12725667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.